Inventor · disambiguated record
Brian C. Cunningham
Also filed as: CUNNINGHAM BRIAN C · CUNNINGHAM BRIAN T
32 granted patents·5 pending applications·3,679 citations·filing 1981–2006
98Inventor score
Files withGENENTECH INC26GENENCOR INT6STAUFFER CHEMICAL CO1SUNESIS PHARMACEUTICALS INC1WELLS JAMES A1
Top patents by PatentIndex Score
37 records- 0199US5834250AMethod for identifying active domains and amino acid residues in polypeptides and hormone variantsGENENTECH INC·Filed 1997·Granted Nov 10, 1998·432 cites·31 claims
- 0299US5700676AModified subtilisins having amino acid alterationsGENENCOR INT·Filed 1995·Granted Dec 23, 1997·335 cites·57 claims
- 0398US5955340AModified subtilisins having amino acid alterationsGENENCOR INT·Filed 1995·Granted Sep 21, 1999·241 cites·102 claims
- 0498US5849535AHuman growth hormone variantsGENENTECH INC·Filed 1996·Granted Dec 15, 1998·346 cites·22 claims
- 0597US6057292AMethod for inhibiting growth hormone actionGENENTECH INC·Filed 1998·Granted May 2, 2000·198 cites·12 claims
- 0697US5580723AMethod for identifying active domains and amino acid residues in polypeptides and hormone variantsGENENTECH INC·Filed 1994·Granted Dec 3, 1996·212 cites·36 claims
- 0796US6013478AMethod for identifying active domains and amino acid residues in polypeptides and hormone variantsGENENTECH INC·Filed 1998·Granted Jan 11, 2000·184 cites·32 claims
- 0896US5534617AHuman growth hormone variants having greater affinity for human growth hormone receptor at site 1GENENTECH INC·Filed 1993·Granted Jul 9, 1996·236 cites·4 claims
- 0995US5972682AEnzymatically active modified subtilisinsGENENCOR INT·Filed 1994·Granted Oct 26, 1999·62 cites·44 claims
- 1095US5763257AModified subtilisins having amino acid alterationsGENENCOR INT·Filed 1995·Granted Jun 9, 1998·63 cites·5 claims
- 1194US5801038AModified subtilisins having amino acid alterationsGENENCOR INT·Filed 1995·Granted Sep 1, 1998·59 cites·16 claims
- 1294US5506107ASelecting ligand agonists and antagonistsGENENTECH INC·Filed 1992·Granted Apr 9, 1996·167 cites·18 claims
- 1393US6451561B1Growth hormone variantsGENENTECH INC·Filed 1995·Granted Sep 17, 2002·96 cites·19 claims
- 1493US6428954B1Method for identifying active domains and amino acid residues in polypeptides and hormone variantsGENENTECH INC·Filed 1995·Granted Aug 6, 2002·94 cites·49 claims
- 1593US6057428AVariants of vascular endothelial cell growth factorGENENTECH INC·Filed 1996·Granted May 2, 2000·90 cites·20 claims
- 1693US6022711AHuman growth hormone variants having enhanced affinity for human growth hormone receptor at site 1GENENTECH INC·Filed 1995·Granted Feb 8, 2000·100 cites·8 claims
- 1793US5854026AHuman growth hormone variant having enhanced affinity for human growth hormone receptor at site 1GENENTECH INC·Filed 1995·Granted Dec 29, 1998·78 cites·6 claims
- 1892US6004931AMethod for inhibiting growth hormone actionGENENTECH INC·Filed 1998·Granted Dec 21, 1999·85 cites·12 claims
- 1991US6143523AHuman growth hormone variantsGENENTECH INC·Filed 1995·Granted Nov 7, 2000·84 cites·6 claims
- 2090US6800740B1Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modificationsGENENTECH INC·Filed 1995·Granted Oct 5, 2004·77 cites·25 claims
- 2190US6136563AHuman growth hormone variants comprising amino acid substitutionsGENENTECH INC·Filed 1998·Granted Oct 24, 2000·67 cites·17 claims
- 2289US8637646B2Growth hormone variantsWELLS JAMES A·Filed 2002·Granted Jan 28, 2014·15 cites·6 claims
- 2389US5846932AReceptor specific atrial natriuretic peptidesGENENTECH INC·Filed 1995·Granted Dec 8, 1998·79 cites·14 claims
- 2488US6465235B1Non-human carbonyl hydrolase mutants, DNA sequences and vectors encoding same and hosts transformed with said vectorsGENENCOR INT·Filed 1997·Granted Oct 15, 2002·32 cites·48 claims
- 2587US5955346AVariants of human prolactin and human placeatal lactogenGENENTECH INC·Filed 1995·Granted Sep 21, 1999·54 cites·26 claims
- 2681US6780613B1Growth hormone variantsGENENTECH INC·Filed 1995·Granted Aug 24, 2004·49 cites·51 claims
- 2781US6525022B1Receptor specific atrial natriuretic peptidesGENENTECH INC·Filed 1998·Granted Feb 25, 2003·35 cites·27 claims
- 2879US5665704AReceptor specific atrial natriuretic peptidesGENENTECH INC·Filed 1995·Granted Sep 9, 1997·56 cites·14 claims
- 2978US6936440B1Selecting ligand agonists and antagonistsGENENTECH INC·Filed 1995·Granted Aug 30, 2005·25 cites·9 claims
- 3077US6376524B1Triphenyl compounds as interleukin-4 antagonistsSUNESIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 23, 2002·14 cites·15 claims
- 3175US7090834B1Vascular endothelial cell growth factor variants and uses thereofGENENTECH INC·Filed 2000·Granted Aug 15, 2006·7 cites·55 claims
- 3260US2006269997A1Vascular endothelial cell growth factor variants and uses thereofGENENTECH INC·Filed 2006·Application pending·0 cites
- 3344US2002187464A1Microarray-based method for rapid identification of cells, microorganisms, or protein mixturesFiled 2001·Application pending·0 cites
- 3439US4506010AMethod for testing microbial degradation of celluloseSTAUFFER CHEMICAL CO·Filed 1981·Granted Mar 19, 1985·7 cites·2 claims
- 3538US2006063203A1Vascular endothelial cell growth factor variants and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 3636US2003022361A1Smart culture vesselFiled 2002·Application pending·0 cites
- 3732US2007142284A1Vascular endothelial cell growth factor variants and uses thereofGENENTECH INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian C. Cunningham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →